PCV72 COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66370-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)66370-X/fulltext
Section Title :
Section Order :
205
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66370-X&doi=10.1016/S1098-3015(10)66370-X